Troy, Michigan – Woodbridge is to buy all the shares in the joint venture Woodbridge GSK High Polymer Technology from its partner, GSK Corporation.
Moulded foam manufacturing at Wuhan (WGSK), Guangzhou (Guangzhou Woodbridge GSK High Polymer Technology Co) and Shanghai (Shanghai Woodbridge GSK Auto Parts Co) are included in the deal.
No price was disclosed.
'Woodbridge has been the management partner and technology provider of these three sites for 14 years,' said Woodbridge CEO Charles Daly.
Woodbridge will continue to supply moulded polyurethane components to GSK for seat assemblies.